Notice of Results
Cambridge Cognition Holdings plc
("Cambridge Cognition" or the "Company")
Notice of Results
Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, will announce its interim results for the six months to 30 June 2020 on 22 September 2020.
Enquiries:
Cambridge Cognition Holdings plc | Tel: 01223 810 700 |
Matthew Stork, Chief Executive Officer | |
Nick Walters, Chief Financial Officer | |
finnCap Ltd (Nomad and Joint Broker) | Tel: 020 7220 0500 |
Geoff Nash/ Simon Hicks | (Corporate Finance) |
Alice Lane/ Manasa Patil | (Corporate Broking) |
Dowgate Capital Limited (Joint Broker) | Tel: 020 3903 7715 |
David Poutney/ James Serjeant | |
IFC Advisory Ltd (Financial PR and IR) | Tel: 020 3934 6630 |
Tim Metcalfe/ Graham Herring/ Zach Cohen |
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit www.cambridgecognition.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.